cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Nanostring Technologies Inc
1 own
6 watching
Current Price
$12.08
$-0.49
(-3.9%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
563.35M
52-Week High
52-Week High
41
52-Week Low
52-Week Low
4.37
Average Volume
Average Volume
0.6M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization563.35M
icon52-Week High41
icon52-Week Low4.37
iconAverage Volume0.6M
iconDividend Yield--
iconP/E Ratio--
What does the Nanostring Technologies Inc do?
NanoString Technologies, Inc. develops, manufactures, and sells life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include nCounter Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples through the images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; and Pan Cancer pathways gene expression panels, including pathways, immune profiling, and progression panels, as well as nCounter Vantage 3D, other gene expression, miRNA expression, and cancer copy number variation panels. Further, the company offers nCounter Elements reagents that allow users to design customized assays for gene expression, copy number variation, and gene fusions; Master Kits, which include ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and nCounter Dx Analysis System and Prosigna molecular diagnostic test kits. It markets its systems and related consumables to researchers in academic, government, and biopharmaceutical laboratories, as well as to clinical laboratories and medical centers. NanoString Technologies, Inc. has collaboration with Celgene Corporation; Merck Sharp & Dohme Corp.; Medivation, Inc.; and Astellas Pharma, Inc. The company was founded in 2003 and is headquartered in Seattle, Washington.
Read More
How much money does Nanostring Technologies Inc make?
News & Events about Nanostring Technologies Inc.
Benzinga
2days ago
Latest Ratings for NSTG DateFirmActionFromTo Mar 2022JP MorganMaintainsOverweight May 2021Morgan StanleyMaintainsEqual-Weight Mar 2021Morgan StanleyMaintainsEqual-Weight View More Analyst Ratings for NSTG View the Latest Analyst Ratings read more...
Business Wire
27days ago
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the fourth quarter and fiscal year ended December 31, 2022. NanoString continued to build on our strong...
Business Wire
1month ago
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the companys management is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference. Brad Gray, president and chief executive...
Business Wire
1month ago
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced that the companys CosMx Spatial Molecular Imager (SI) has been recognized by The Scientist magazine as one of the Top 10 Innovations of the 2022...
Ticker Report
7 months ago
NanoString Technologies, Inc. (NASDAQ:NSTG Get Rating) Director Elisha W. Finney sold 1,945 shares of the businesss stock in a transaction on Friday, June 17th. The shares were sold at an average price of $12.41, for a total transaction of $24,137.45. Following the completion of the ...
Frequently Asked Questions
Frequently Asked Questions
What is Nanostring Technologies Inc share price today?
plus_minus_icon
Can Indians buy Nanostring Technologies Inc shares?
plus_minus_icon
How can I buy Nanostring Technologies Inc shares from India?
plus_minus_icon
Can Fractional shares of Nanostring Technologies Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Nanostring Technologies Inc stocks?
plus_minus_icon
What is today’s traded volume of Nanostring Technologies Inc?
plus_minus_icon
What is today’s market capitalisation of Nanostring Technologies Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Nanostring Technologies Inc?
plus_minus_icon
What percentage is Nanostring Technologies Inc down from its 52-Week High?
plus_minus_icon
What percentage is Nanostring Technologies Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$12.08
$-0.49
(-3.9%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Mesoblast
Mesoblast
$3.66
$0.02 (0.55 %)
Coherus BioSciences Inc
Coherus BioSciences Inc
$8.49
$-0.47 (-5.25 %)
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc.
$1.91
$0.12 (6.70 %)
bluebird bio, Inc.
bluebird bio, Inc.
$6.65
$0.02 (0.30 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Mesoblast
Mesoblast
$3.66
$0.02 (0.55 %)
Coherus BioSciences Inc
Coherus BioSciences Inc
$8.49
$-0.47 (-5.25 %)
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc.
$1.91
$0.12 (6.70 %)
bluebird bio, Inc.
bluebird bio, Inc.
$6.65
$0.02 (0.30 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00